A Liver-Selective LXR Inverse Agonist That Suppresses Hepatic Steatosis
Author:
Affiliation:
1. The Scripps Research Institute, Jupiter, Florida 33458, United States
Publisher
American Chemical Society (ACS)
Subject
Molecular Medicine,General Medicine,Biochemistry
Link
https://pubs.acs.org/doi/pdf/10.1021/cb300541g
Reference30 articles.
1. Prevalence of hepatic steatosis in an urban population in the United States: Impact of ethnicity
2. Magnetic resonance spectroscopy to measure hepatic triglyceride content: prevalence of hepatic steatosis in the general population
3. Treatment of non-alcoholic fatty liver disease
4. Molecular mediators of hepatic steatosis and liver injury
5. Human Fatty Liver Disease: Old Questions and New Insights
Cited by 89 articles. 订阅此论文施引文献 订阅此论文施引文献,注册后可以免费订阅5篇论文的施引文献,订阅后可以查看论文全部施引文献
1. The roles of nuclear receptors in cholesterol metabolism and reverse cholesterol transport in nonalcoholic fatty liver disease;Hepatology Communications;2023-12-15
2. Development and pharmacological evaluation of a new chemical series of potent pan-ERR agonists, identification of SLU-PP-915;European Journal of Medicinal Chemistry;2023-10
3. Characterization of an in vitro steatosis model simulating activated de novo lipogenesis in MAFLD patients;iScience;2023-10
4. International Union of Basic and Clinical Pharmacology CXIII: Nuclear Receptor Superfamily—Update 2023;Pharmacological Reviews;2023-08-16
5. Genetic perturbation of AMP biosynthesis extends lifespan and restores metabolic health in a naturally short-lived vertebrate;Developmental Cell;2023-08
1.学者识别学者识别
2.学术分析学术分析
3.人才评估人才评估
"同舟云学术"是以全球学者为主线,采集、加工和组织学术论文而形成的新型学术文献查询和分析系统,可以对全球学者进行文献检索和人才价值评估。用户可以通过关注某些学科领域的顶尖人物而持续追踪该领域的学科进展和研究前沿。经过近期的数据扩容,当前同舟云学术共收录了国内外主流学术期刊6万余种,收集的期刊论文及会议论文总量共计约1.5亿篇,并以每天添加12000余篇中外论文的速度递增。我们也可以为用户提供个性化、定制化的学者数据。欢迎来电咨询!咨询电话:010-8811{复制后删除}0370
www.globalauthorid.com
TOP
Copyright © 2019-2024 北京同舟云网络信息技术有限公司 京公网安备11010802033243号 京ICP备18003416号-3